• Skip to main content
  • Skip to primary sidebar
Pediatric Pulmonology: The Remaining Barriers to Normalcy in Cystic Fibrosis

The Remaining Barriers to Normalcy in Cystic Fibrosis

  • Issues
  • Resources
  • About
  • Contact
  • Search

Issues

All issues of “The Remaining Barriers to Normalcy in Cystic Fibrosis” are available with free access through this website.

  • Journal coverThe Remaining Barriers to Normalcy in Cystic Fibrosis I
    October 2015
  • Journal coverThe Remaining Barriers to Normalcy in Cystic Fibrosis II
    October 2016
  • Journal coverThe Remaining Barriers to Normalcy in Cystic Fibrosis III
    November 2017
  • Journal coverThe Remaining Barriers to Normalcy in Cystic Fibrosis IV
    November 2018
  • Journal coverThe Remaining Barriers to Normalcy in Cystic Fibrosis V
    November 2019
  • Journal coverThe Remaining Barriers to Normalcy in Cystic Fibrosis VI
    February 2021
  • Cover of Pediatric Pulmonology: The Remaining Barriers to Normalcy in Cystic Fibrosis VIIThe Remaining Barriers to Normalcy in Cystic Fibrosis VII
    February 2022

Primary Sidebar

Most Viewed Articles

  • Rapid therapeutic advances in CFTR modulator science

  • Reevaluating approaches to cystic fibrosis pulmonary exacerbations

  • Breakthrough therapies: Cystic fibrosis (CF) potentiators and correctors

  • Recent advances in the early treatment of cystic fibrosis: Bridging the gap to highly effective modulator therapy

  • Inflammation in cystic fibrosis: An update

Quiz and Survey

Test your knowledge and help shape future editions of "The Remaining Barriers to Normalcy." Participate in our Quiz and Survey »

This website is made possible by an educational grant from Vertex Pharmaceuticals Incorporated.

Vertex

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2018-2025 John Wiley & Sons, Inc. All Rights Reserved.
The content on this site is intended for health professionals.
Wiley